“The Molecular Microscope® Diagnostic System: Defining Rejection and Injury in Biopsies by Gene Expression”

Wednesday, December 2, 2020      7:00 – 8:00 a.m.

https://duke.zoom.us/j/95366546086?pwd=V1pUd2ZmdEFRdjBwNkxmRkxoMC8zUT09

Moderator:   Allan Kirk, MD

Disclosures:  Dr. Kirk – MedBlue Data (Stockholder, Other) Semma Therapeutics (Adv Bd)  MedBlue (Other) BMS (PI), Dr. Halloran – Novartis (Grant), Astellas (Speaker) One Lambda (Speaker) Bristol Myers Squibb (Speaker) Transcriptome Sciences, Inc (Employee, Stockholder))